Bio-Matrix Scientific Group Inc (BMSN)

Bio-Matrix Scientific Group, Inc., was organized October 6, 1998, under the laws of the State of Delaware as Tasco International, Inc. It is in the development stage. The Company intends to engage mainly in: providing biospecimen depository services, namely offering cryopreservation of cellular specimens as well as laboratory processing of cellular specimens and through Entest, its majority owned subsidiary, developing and commercializing therapies, medical devices and medical testing procedures. Biospecimen depository services are intended to be provided at its 14,562 sq. ft. facility. The facility houses two secure cryogenic stem cell banks, three research laboratories, and aseptic cellular/tissue class 10,000/100 processing lab as well as hematology, microbiology and flow cytometry laboratories. Entest intends to develop and commercialize therapies, medical devices and medical testing procedures. The current strategy of Entest is to license intellectual property (IP) for development and commercialization by Entest and fund the development of internally developed IP through obtaining of grants from governmental and other entities. The industries in which it intends to compete are highly competitive.